ESC 365 - How should we manage chronic coronary syndromes after the ISCHEMIA trial?

ESC Premium Access

How should we manage chronic coronary syndromes after the ISCHEMIA trial?

Session: Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial

Topic: Clinical

Speaker: Doctor F. Otsuka (Suita, JP)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Fumiyuki Otsuka

Suita (Japan)

1 presentation

0 follower

4 more presentations in this session

Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.

Speaker: Assistant Professor S. Kohsaka (Tokyo, JP)

Is there a need to revise the ESC Guidelines for myocardial revascularisation and chronic coronary syndromes because of the ISCHEMIA trial?

Speaker: Doctor B. Gersh (Rochester, US)

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial - Chat Moderator.

Access the full session

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial

Speakers: Doctor F. Otsuka, Assistant Professor S. Kohsaka, Doctor B. Gersh

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: what do the guidelines say?

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

Colchicine in Acute Myocardial Infarction

27 August 2021

ESC 365 is supported by